Serum prolactin and response to treatment among cocaine‐dependent individuals

Abstract Considerable evidence indicates that dopaminergic mechanisms may modulate the central effects of cocaine. We investigated whether basal serum prolactin, a measure of central dopamine activity, differed between cocaine‐dependent subjects and controls, and whether prolactin levels among cocaine patients were related to their response to treatment. Eighty‐six African‐American cocaine‐dependent outpatients and 35 African‐American controls were studied. Prolactin concentrations in fasting blood samples were assayed by radioimmunoassay. The outcome measures were: number of negative urine drug screens, retention in treatment, counselor ratings of improvement and discharge status. Chi‐square tests and independent t ‐tests were used for data analyses. The basal prolactin(ng/ml) among cocaine patients (9.12 ± 4.12) was significantly higher compared to controls (7.14 ± 3.36) (t = 2.52, p < 0.02). Furthermore, the higher prolactin subjects (median prolactin = 7.71) had significantly fewer negative urine screens (p < 0.05) and received less favorable ratings of improvement by counselors (p < 0.01) compared to the lower prolactin group. However, the two groups did not differ significantly in treatment retention (p = 0.13) or discharge status (p = 0.08). The higher basal prolactin among cocaine patients relative to controls may reflect changes in DA activity among cocaine patients. Moreover, higher prolactin seems to be related negatively with certain measures of response to treatment among cocaine patients.

[1]  Patrick M. O'Malley,et al.  National Survey Results on Drug Use from the Monitoring the Future Study, 1975-1998. Volume I: Secondary School Students. , 1999 .

[2]  G. Aghajanian,et al.  Molecular and cellular basis of addiction. , 1997, Science.

[3]  J. Mendelson,et al.  Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical Studies , 1997, Pharmacology Biochemistry and Behavior.

[4]  L. Laster,et al.  Efficacy of outpatient intensive treatment for drug abuse. , 1997, Journal of addictive diseases.

[5]  S. Weinstein,et al.  Pretreatment dropouts: characteristics and outcomes. , 1997, Journal of addictive diseases.

[6]  G. Grissom.  Treatment Outcomes in Inpatient and Substance Abuse Programs , 1997 .

[7]  J. Henningfield,et al.  Endocrine responses during acute nicotine withdrawal , 1996, Pharmacology Biochemistry and Behavior.

[8]  J. Henningfield,et al.  Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers , 1995, Biological Psychiatry.

[9]  L. Kar,et al.  Monoaminergic Regulation of Neuroendocrine Function and Its Modification by Cocaine , 1994, Frontiers in Neuroendocrinology.

[10]  J. Mendelson,et al.  Serum prolactin levels and treatment outcome in cocaine dependence , 1994, Biological Psychiatry.

[11]  R. Rothman,et al.  Effects of acute and chronic cocaine on the activity of tuberoinfundibular dopamine neurons in the rat , 1993, Brain Research.

[12]  T. Kosten,et al.  Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. , 1992, Archives of general psychiatry.

[13]  Athina Markou,et al.  Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration , 1992, Brain Research.

[14]  C. McDougle,et al.  Dopaminergic responsivity during cocaine abstinence: a pilot study , 1992, Psychiatry Research.

[15]  M. Kuhar,et al.  Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. , 1992, Journal of medicinal chemistry.

[16]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[17]  J. Mendelson,et al.  Hyperprolactinemia and risk for relapse of cocaine abuse , 1990, Biological Psychiatry.

[18]  H. Meltzer,et al.  Neuroendocrine measures of dopaminergic function in chronic cocaine users , 1990, Psychiatry Research.

[19]  C. Swartz,et al.  Serum prolactin levels during extended cocaine abstinence. , 1990, The American journal of psychiatry.

[20]  K. Fuxe,et al.  Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications , 1989, Psychoneuroendocrinology.

[21]  J. Jaffe,et al.  Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers , 1989, Biological Psychiatry.

[22]  Karl Fagerstrom,et al.  Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire , 1989, Journal of Behavioral Medicine.

[23]  J. Mendelson,et al.  Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. , 1988, The American journal of psychiatry.

[24]  M. Gold,et al.  Sexual dysfunction secondary to cocaine abuse in two patients. , 1986, The Journal of clinical psychiatry.

[25]  H. Kleber,et al.  Neuroendocrine Findings in Chronic Cocaine Abusers: A Preliminary Report , 1985, British Journal of Psychiatry.

[26]  M. Gold,et al.  New concepts in cocaine addiction: The dopamine depletion hypothesis , 1985, Neuroscience & Biobehavioral Reviews.

[27]  J. Tuomisto,et al.  Neurotransmitter regulation of anterior pituitary hormones. , 1985, Pharmacological reviews.

[28]  F. J. Evans,et al.  New Data from the Addiction Severity Index Reliability and Validity in Three Centers , 1985, The Journal of nervous and mental disease.

[29]  M. Jarvik,et al.  Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers , 1982, Psychopharmacology.

[30]  S. Bulusu,et al.  Circulating gonadotropin profile in severe cases of protein calorie malnutrition. , 1982, Fertility and sterility.

[31]  P. Plotsky,et al.  Dopamine in hypophysial stalk blood of the rhesus monkey and its role in regulating prolactin secretion. , 1981, Endocrinology.

[32]  F. Baekeland,et al.  Dropping out of treatment: a critical review. , 1975, Psychological bulletin.

[33]  J. Cook,et al.  Measurement of serum ferritin by a 2-site immunoradiometric assay. , 1974, Analytical biochemistry.

[34]  F. Weiss,et al.  Role for the mesocortical dopamine system in the motivating effects of cocaine. , 1994, NIDA research monograph.

[35]  M. Gold,et al.  Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics. , 1993, Journal of addictive diseases.

[36]  H. Kranzler,et al.  Serum prolactin level, craving, and early discharge from treatment in cocaine-dependent patients. , 1992, The American journal of drug and alcohol abuse.

[37]  B. Rounsaville,et al.  Interpersonal psychotherapy adapted for ambulatory cocaine abusers. , 1985, The American journal of drug and alcohol abuse.

[38]  N. Beck,et al.  Prediction of discharges against medical advice from an alcohol and drug misuse treatment program. , 1983, Journal of studies on alcohol.

[39]  G. Baumann,et al.  The effect of osmotic stimuli on prolactin secretion and renal water excretion in normal man and in chronic hyperprolactinemia. , 1977, The Journal of clinical endocrinology and metabolism.